Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

Related Articles by Review for PubMed (Select 15470215)

1.

Lamivudine for patients with chronic hepatitis B and advanced liver disease.

Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, Dixon JS, Gray DF, Sabbat J; Cirrhosis Asian Lamivudine Multicentre Study Group.

N Engl J Med. 2004 Oct 7;351(15):1521-31.

2.

Treatment of chronic hepatitis B: case selection and duration of therapy.

Leung N.

J Gastroenterol Hepatol. 2002 Apr;17(4):409-14. Review.

PMID:
11982721
3.

Lamivudine treatment in patients with chronic hepatitis B and cirrhosis.

Haché C, Villeneuve JP.

Expert Opin Pharmacother. 2006 Sep;7(13):1835-43. Review.

PMID:
16925509
4.

Prevention of hepatocellular carcinoma in hepatitis B virus infection.

Lim SG, Mohammed R, Yuen MF, Kao JH.

J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. Review.

PMID:
19702903
5.

Management of viral hepatitis B.

Pramoolsinsup C.

J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S125-45. Review.

PMID:
12000599
6.

Liver disease-significant improvement with lamivudine.

Leung N.

J Med Virol. 2000 Jul;61(3):380-5. Review.

PMID:
10861650
7.

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A.

J Hepatol. 2010 Aug;53(2):348-56. doi: 10.1016/j.jhep.2010.02.035. Epub 2010 Apr 27. Review.

8.

[Prevention for the development of hepatitis B virus-related hepatocellular carcinoma by anti-viral treatment].

Ebinuma H, Saito H.

Nihon Rinsho. 2011 May;69 Suppl 4:540-5. Review. Japanese. No abstract available.

PMID:
22096977
9.

Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy.

Peng CY, Chien RN, Liaw YF.

J Hepatol. 2012 Aug;57(2):442-50. doi: 10.1016/j.jhep.2012.02.033. Epub 2012 Apr 12. Review.

10.

Management of end-stage liver disease in chronic hepatitis B.

Tan HH, Martin P.

Clin Liver Dis. 2010 Aug;14(3):477-93. doi: 10.1016/j.cld.2010.05.006. Review.

PMID:
20638026
11.

A proposed, evidence-based approach to the treatment of chronic Hepatitis B.

Han SH, Durazo FA, Saab S, Tong MJ.

J Clin Gastroenterol. 2011 Mar;45(3):259-66. doi: 10.1097/MCG.0b013e3181f312f5. Review.

PMID:
20856136
12.

Impact of therapy on the long-term outcome of chronic hepatitis B.

Liaw YF.

Clin Liver Dis. 2013 Aug;17(3):413-23. doi: 10.1016/j.cld.2013.05.005. Epub 2013 Jun 21. Review.

PMID:
23905813
13.

Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs.

Brown A, Goodman Z.

Expert Rev Gastroenterol Hepatol. 2012 Apr;6(2):187-98. doi: 10.1586/egh.12.4. Review.

PMID:
22375524
14.

Regression of fibrosis after HBV antiviral therapy. Is cirrhosis reversible?

Calvaruso V, Craxì A.

Liver Int. 2014 Feb;34 Suppl 1:85-90. doi: 10.1111/liv.12395. Review.

PMID:
24373083
15.

Nucleot(s)ide analogues for hepatitis B virus-related hepatocellular carcinoma after curative treatment: a systematic review and meta-analysis.

Sun P, Dong X, Cheng X, Hu Q, Zheng Q.

PLoS One. 2014 Jul 24;9(7):e102761. doi: 10.1371/journal.pone.0102761. eCollection 2014. Review.

16.

Management of chronic hepatitis B.

Massoumi H, Martin P, Tan HH.

Eur J Gastroenterol Hepatol. 2011 Aug;23(8):642-50. doi: 10.1097/MEG.0b013e3283474add. Review.

PMID:
21602690
17.

Active antiviral therapy for chronic hepatitis B and hepatocellular carcinoma.

Hann HW.

Minerva Gastroenterol Dietol. 2008 Mar;54(1):19-30. Review.

PMID:
18299665
18.

[Introduction to chronic hepatitis type B].

Inoue O, Nakagawa Y, Mawatari H.

Nihon Rinsho. 2004 Aug;62 Suppl 8:285-9. Review. Japanese. No abstract available.

PMID:
15453331
19.

Long-term nucleos(t)ide analogues therapy for adults with chronic hepatitis B reduces the risk of long-term complications: a meta-analysis.

Zhang QQ, An X, Liu YH, Li SY, Zhong Q, Wang J, Hu HD, Zhang DZ, Ren H, Hu P.

Virol J. 2011 Feb 15;8:72. doi: 10.1186/1743-422X-8-72. Review.

20.

Advanced liver disease: what every hepatitis C virus treater should know.

Sherman KE.

Top Antivir Med. 2011 Aug-Sep;19(3):121-5. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk